pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

LEO Pharma Inc

updated 5mo ago
community read0 votes

🐶 often sniffed alongside

top 7
  • tagApproval64 co-mentions · 32 sources
  • drugDOVONEX50 co-mentions · 25 sources
  • companyLeo Pharma AS32 co-mentions · 32 sources
  • drugcalcipotriene25 co-mentions · 25 sources
  • drugtralokinumab20 co-mentions · 8 sources
  • drugADBRY20 co-mentions · 8 sources
  • tagRecall3 co-mentions · 1 sources
pipeline
3
marketed
3
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(3)

pipeline depth3 products
Marketed: 3
3Marketed
Marketed
Finacea
Rosacea
Marketed
Protopic
Atopic Dermatitis (Atopic Eczema)
Marketed
tralokinumab
Atopic Dermatitis (Atopic Eczema)

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view LEO Pharma Inc jobs →

News

  • Disc’s once-spurned rare disease drug to get a second chance at approval
    Months after the FDA rejected its treatment for a rare light-sensitivity disease, the biotech claimed success in a Phase 3 trial and now plans to re-engage regulators.
    biopharma_dive · 1mo ago
  • 6 immunology targets to sustain a mammoth I&I market
    Johnson & Johnson, Pfizer, Argenx and more are unlocking new immunology targets and looking to improve on existing ones in an attempt to catch some of the magic brought about by AbbVie’s Humira and…
    biospace · 1mo ago
  • Leo Pharma buys rare skin disease drug in $435M deal
    Tanabe Pharma has already asked the FDA to approve the medicine for two conditions that cause severe reactions to sunlight.
    biopharma_dive · 3mo ago
  • LEO adds to dermatology portfolio with $435M deal for late-stage rare disease drug
    This is the third recent acquisition conducted by Denmark’s LEO Pharma in medical dermatology, a portfolio that marked 12% growth in the first half of the year.
    biospace · 3mo ago
  • Leo Pharma to license Tanabe’s rare disease drug for pain with sun exposure
    Leo Pharma said it will pay Japan’s Tanabe Pharma up to $435 million in upfront and near-term payments to license an oral drug for a pair of genetic light-sensitive skin diseases. The Danish biotec…
    endpoints · 3mo ago
  • Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nod
    Leo Pharma is sticking to its mission of strengthening its pipeline in 2026, penning a $435 million deal for a rare skin disease drug from Tanabe Pharma that's awaiting an approval decision by the…
    fiercebiotech · 3mo ago
  • Chasing Dupixent, a biotech aims to make better antibody drugs for eczema
    Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.
    biopharma_dive · 3mo ago
identifiers
source
globaldata
top tags
Dermatology1
mentioned in
7news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?